BioSpace News Archive

Regulatory and Quality Solutions LLC —a leading provider of regulatory and quality consulting services for medical devices, in vitro diagnostic devices, and combination products— announced that it has acquired Maetrics LLC, an international leader in life sciences quality and regulatory consulting.

Biofidelity Ltd, the cancer diagnostics company, announces the appointment of Dr. Heiner Dreismann, former President and CEO of Roche Molecular Systems, as Chairman with immediate effect.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, announced that cytisinicline data will be featured in two presentations on Friday, September 18th, at the SRNT-E virtual conference.

Thinking differently about thinking – Development plans for SAGE-718 focused on executive function across multiple indications Early learnings from studies of other compounds created multi-faceted insights for SAGE-324 program in essential tremor Interview with investigator from SHORELINE study highlights potential for multiple approaches in the treatment of MDD Additional details about Phase 3 trial with brexanolone in COVID-19 related

Merck to Present at the Morgan Stanley 18th Annual Virtual Global Healthcare Conference ,

AIM ImmunoTech Inc. (NYSE American:AIM) today announced that the company will be presenting at the H.C. Wainwright Annual Global Investment Conference, being held virtually on September 14-16, 2020.

AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its financial results for the six months ended June 30, 2020. Financial Highlights for the First Six Months of 2020 Total revenues were RMB4.1 million (US$0.6 million) for the first six months of 2020, an increase of 3.4% from RMB3.9 million for the first six mo

Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that Jerome D. Jabbour, Chief Executive Officer, has been invited to participate on a panel of top innovators in anti-infective drug development as part of Maxim Group’s M-VEST Virtual Conference Series. Date: Thursday, September 17, 2020 Panel details: A discussion among CEOs of top anti-fungal innovators, moderated by Maxim Group analyst, Jason McCarthy, Ph.D. Time

MISSISSAUGA, Ontario, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix ® ), an award-winning life sciences innovator and exporter, is pleased to announce attainment of Australian Therapeutic Goods Administration (TGA) registration for its COVID-19 and high-risk HPV quality assessment products (QAPs™) – TGA registration of these REDx™ Controls & REDx™FLOQ ® products by Microbix’s distributor, R-Biopharm, enables it to offer these workflow contro

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that it will present clinical data on AXS-05 in the treatment of major depressive disorder (MDD) at the 33 rd Congress of the European College of Neuropsychopharmacology (ECNP), to be held virtually, September 12-15. AXS-05 (dextromethorphan/bupropion modulated delivery tablet